The short-term effects of berberine in the liver: Narrow margins ...
网页2022年9月1日 · Berberine is a plant alkaloid to which antihyperglycemic properties have been attributed. It is also known as an inhibitor of mitochondrial functions. In this work short-term translation of the latter effects on hepatic metabolism were investigated using the isolated perfused rat liver. Once-through …
Update on Berberine in Nonalcoholic Fatty Liver Disease
网页2013年6月17日 · Berberine (BBR), an active ingredient from nature plants, has demonstrated multiple biological activities and pharmacological effects in a series of metabolic diseases including nonalcoholic fatty liver disease (NAFLD). The recent literature points out that BBR may be a potential drug for NAFLD in …
The clinical efficacy and safety of berberine in the treatment of …
网页2024年3月1日 · Berberine can modulate the physiological axis connecting the gut and the liver, leading to a balanced composition of intestinal microbes, maintenance of intestinal integrity, and reduction in enterogenic endotoxins entering the liver.
Berberine - LiverTox - NCBI Bookshelf - National Center for ...
网页2020年10月6日 · Despite wide scale use as an herbal supplement, berberine has not been linked to published instances of clinically apparent liver injury. The frequency of hypersensitivity reactions to berberine is also not known.
Berberine in Non-Alcoholic Fatty Liver Disease—A Review
网页2022年8月23日 · One of the most promising is Berberine (BBR). Its pleiotropic effect positively impacts various cardiometabolic aspects. In this review, we summarize NAFLD, its metabolic and cardiovascular complications, the hepatoprotective effects of BBR due to its broad spectrum of pharmacological effects, and the potential role of BBR in NAFLD therapy.
The short-term effects of berberine in the liver: Narrow margins ...
网页2022年9月1日 · Berberine decreases gluconeogenesis and increases glycolysis in the perfused liver. • Berberine impairs hepatic ammonia detoxification. • Berberine diminishes liver ATP content and increases NADH/NAD+ ratio. • Effects are a consequence of impairment on mitochondrial respiration and pyruvate carboxylation. •
Molecular updates on berberine in liver diseases: Bench to bedside
网页The use of phytochemicals for the amelioration of liver diseases has gained considerable popularity. Berberine (BBR), an isoquinoline alkaloid of the protoberberine type, has emerged as a promising molecule for the treatment of gastrointestinal disorders. Accumulating studies have proved the hepatoprotective effects of BBR.
Berberine improves glucogenesis and lipid metabolism in …
网页2017年2月28日 · 67 Citations. 10 Altmetric. Metrics. Abstract. Background. Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti-dyslipidemic effects and can also ameliorate NAFLD.
A phase 2, proof of concept, randomised controlled trial of berberine …
网页2021年9月17日 · Here the authors report an 18-week phase 2, randomised, double-blind, placebo-controlled clinical trial that tested the effect of berberine ursodeoxycholate in patients with fatty liver disease...
Berberine in Non-Alcoholic Fatty Liver Disease-A Review
网页2022年8月23日 · BBR ameliorates NAFLD by affecting numerous abnormalities. It inhibits lipogenesis and gluconeogenesis, improves insulin resistance and lipid profile, and modulates gut microbiota. The exact mechanism underlying these …
- 某些结果已被删除